glp 1 mash approval GLP-1 therapies: a new frontier in treatment The FDA has approved Wegovy

The toll is physical and financial, with the medical cost of obesity hitting nearly $173 billion in 2019 in the U.S

Bofanglutide is a biweekly (once every 2 weeks) injection compared to once-weekly shots like Ozempic and Wegovy

Navigating the clinical trial and regulatory approval process presents a major challenge impeding market expansion

Mechanistically, ANGPTL4/8 appears to promote matrix degradation and the production of inflammatory cytokines like TNF- through the activation of the NF-B signaling pathway (161, 162)

In the pancreas, it stimulates glucose-dependent insulin secretion and suppresses glucagon release, which together help lower blood sugar levels